Todd Foley
InvestorFounderManaging Director at MPM BioImpact · Co-founder and Chairman at Aktis Oncology
Boston, Massachusetts
FoundedAktis Oncology
Find your path to Todd
Sign up to see every warm intro you have to Todd
- Paths you didn't know you had: your email and LinkedIn already hold routes to Todd. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Managing Director who joined MPM in 1999 and chairs several portfolio company boards including Aktis Oncology and Crossbow Therapeutics; previously worked in business development at Genentech. Holds an M.B.A. from Harvard Business School.
Contact· self-published, not guessed
Co-founder and Chairman at Aktis Oncology
Intro paths
In turn, Todd can intro founders to Aktis Oncology's investors below.
Aktis Oncology's investors · 12
Co-founders at Aktis Oncology

Deals · 7
Moat BiotechnologyBoard seat
via MPM BioImpact · filed Oct 2025 · $15.6M raise
Crossbow TherapeuticsBoard seat
via MPM BioImpact · filed Sep 2025 · $80M raise
Firefly Bio, Inc.Board seat
via MPM BioImpact · filed Mar 2024 · $72M raise
Entrada Therapeutics, Inc.Board seat
via MPM BioImpact · filed Apr 2021 · $116.2M raise
HotKnot Therapeutics, Inc.Board seat
via MPM BioImpact · filed Feb 2021 · $72M raise
Tetherex Pharmaceuticals CorpBoard seat
via MPM BioImpact · filed Dec 2020
Clinical inkBoard seat
via MPM BioImpact · filed Dec 2017 · $2.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
Aktis OncologyāshibioCelladonChiasmaIconic TherapeuticsSelexys PharmaceuticalsSemma Therapeutics
Sources: SEC Form D filings · curated public sources.
Colleagues at MPM BioImpact
Frequently asked questions
- Who is Todd Foley?
- Managing Director who joined MPM in 1999 and chairs several portfolio company boards including Aktis Oncology and Crossbow Therapeutics; previously worked in business development at Genentech. Holds an M.B.A. from Harvard Business School.
- Where does Todd Foley work?
- Todd Foley is Co-founder and Chairman of Aktis Oncology and Managing Director at MPM BioImpact.
- What companies did Todd Foley found?
- Todd Foley founded Aktis Oncology.
- What boards does Todd Foley sit on?
- Todd Foley holds tracked board seats at Aktis Oncology, Clinical ink, Crossbow Therapeutics, Entrada Therapeutics, Inc., Firefly Bio, Inc., HotKnot Therapeutics, Inc., Moat Biotechnology, Tetherex Pharmaceuticals Corp.
- What companies has Todd Foley invested in?
- Investments tracked here include Aktis Oncology, āshibio, Celladon, Chiasma, Clinical ink, Crossbow Therapeutics, Firefly Bio, Inc., Iconic Therapeutics, Selexys Pharmaceuticals, Semma Therapeutics.
Founder mafias
Massachusetts Institute of Technology mafia1,487
Also came through, then founded or led a company.
Harvard Business School mafia1,305
Also came through, then founded or led a company.
MPM BioImpact mafia14
Also came through, then founded or led a company.
MPM BioImpact mafia6
Also came through, then founded or led a company.
Chiasma mafia4
Also came through, then founded or led a company.
About this profile. Compiled from public sources — MPM BioImpact's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights



























